PSYENCE BIOMEDICAL LTD. — Investor Relations & Filings
Psyence Biomedical Ltd. is a life science biotechnology company developing psychedelic and nature-centered solutions for mental health. The company specializes in creating therapies from naturally derived, non-synthetic psychedelic compounds, primarily psilocybin and ibogaine. Its core therapeutic focus is on palliative care, developing treatments for anxiety and depression in patients with life-threatening illnesses, including Adjustment Disorder in oncology patients. Additionally, Psyence Biomedical investigates the use of its botanical psilocybin for treating Alcohol Use Disorder (AUD) and other substance use disorders. The company employs a vertically integrated strategy, operating a federally licensed, ISO22000 certified facility for psilocybin cultivation and production to support its clinical trials and therapeutic development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-20 | English | |
| 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-17 | English | |
| 6-K Filing | 2026-02-13 | English | |
| 6-K Filing | 2026-02-12 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-29 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-27 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 34691185 | 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-20 | English | ||
| 34662593 | 6-K - PSYENCE BIOMEDICAL LTD. (0001985062) (Filer) | 2026-04-17 | English | ||
| 32277979 | 6-K Filing | 2026-02-13 | English | ||
| 32277962 | 6-K Filing | 2026-02-12 | English | ||
| 13664766 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-29 | English | ||
| 13664765 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-27 | English | ||
| 13664767 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-14 | English | ||
| 13664768 | Major Shareholding Notification 2026 | 2026-01-14 | English | ||
| 13664769 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-13 | English | ||
| 13664771 | CURRENT REPORT | 2026-01-13 | English | ||
| 13664770 | CURRENT REPORT | 2026-01-08 | English | ||
|
2025
4 filings
| |||||
| 13664773 | Major Shareholding Notification 2025 | 2025-12-11 | English | ||
| 13664772 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-21 | English | ||
| 13664775 | PROSPECTUS SUPPLEMENT | 2025-11-20 | English | ||
| 13664774 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-onc…
|
ATORX | SE | Manufacturing |
|
Allmed Medical Products Co., Ltd
Manufacturer of medical dressings, surgical kits, and dispo…
|
002950 | CN | Manufacturing |
|
Allogene Therapeutics, Inc.
Develops off-the-shelf allogeneic CAR T therapies for cance…
|
ALLO | US | Manufacturing |
|
Almirall S.A.
Global biopharmaceutical company specializing in medical de…
|
ALM | ES | Manufacturing |
|
ALNYLAM PHARMACEUTICALS, INC.
A biopharmaceutical company developing RNA interference (RN…
|
ALNY | US | Manufacturing |
|
Alpa Laboratories Limited
WHO-GMP certified manufacturer of human and veterinary phar…
|
ALPA | IN | Manufacturing |
|
Alpha Cognition Inc.
A biopharmaceutical company developing treatments for neuro…
|
ACOG | CA | Manufacturing |
|
Alphamab Oncology
Innovative biopharma specializing in differentiated anti-tu…
|
9966 | KY | Manufacturing |
|
Alpha Teknova, Inc.
Manufacturer of critical reagents for the life sciences ind…
|
TKNO | US | Manufacturing |
|
ALTERITY THERAPEUTICS LTD
A clinical-stage biotech developing novel treatments for ne…
|
ATHE | US | Manufacturing |
PSYENCE BIOMEDICAL LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35492/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35492 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35492 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35492 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35492}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PSYENCE BIOMEDICAL LTD. (id: 35492)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.